How an externship polished me as an OD

Publication
Article
Optometry Times JournalOptometry Times August 2019
Volume 11
Issue 8

It was a special Optometry’s Meeting for me this year. I am humbled and very grateful to all (and there are many) who made me a candidate and recipient of the American Optometric Association’s 2019 OD of the Year. My family and I truly felt the love the entire time we were in St. Louis.

One great and unforeseen addition to a wonderful week was bumping into one of my mentors and an individual I’m honored to call a friend.

I ran into Dr. John Essinger and his wife Ruthann on Wednesday of the conference. We ducked into the front lobby of the AOA’s new headquarters (which is fantastic) and got to catch up for a few seconds. Our brief conversation brought back great memories. Dr. Essinger and Dr. James Fisk afforded me the opportunity to extern at their private practice when I was a fourth-year student at the UAB School of Optometry.

Previously by Dr. Casella: One steroid drop, one time for allergice response

Business of optometry
Looking back, I think all fourth-year students should have the opportunity to perform an externship in a private-practice setting. In the right scenario, it can afford a multifaceted learning experience that is priceless to the young clinician. The business of eye care-optical, insurance, staff-can be daunting to anyone. To me, it can be daunting on a good day.

As an optometry student with a liberal arts degree, it would be an understatement to say I could have used as much training in the world of eyecare business as I could attain. Learning from common-sense experience is something we all could use, and I feel fortunate to have had access to it at a young age.

In addition to being witness to contemporary and innovative patient care, I got to experience the joys and tribulations of day-to-day optometric life besides the clinical side. The lessons I learned during this externship have turned into key facets of my optometric cerebrum which have many times driven my decision making in clinical and business aspects of optometry. Who could ask for a better result from an externship than to have it morph into a legacy of sorts?

I didn’t know it was possible to learn so much and have so much fun at the same time. Such a seemingly false dichotomy seems uncommon, and I’m here to tell you it happened as described. The successful emulation of Drs Essinger and Fisk would mean being a great doctor of optometry in addition to a great human, and I look back at my time at their practice with gratitude, joy, and lots of love.

Read more editorials here

Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
© 2024 MJH Life Sciences

All rights reserved.